175 related articles for article (PubMed ID: 35598400)
1. Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells.
Lee HS; Tamia G; Song HJ; Amarakoon D; Wei CI; Lee SH
Int Immunopharmacol; 2022 Jul; 108():108865. PubMed ID: 35598400
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
5. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB
Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH
Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4.
Huang T; Xu T; Wang Y; Zhou Y; Yu D; Wang Z; He L; Chen Z; Zhang Y; Davidson D; Dai Y; Hang C; Liu X; Yan C
Autophagy; 2021 Nov; 17(11):3592-3606. PubMed ID: 33629929
[TBL] [Abstract][Full Text] [Related]
7. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
Peng J; Fan M; An C; Ni F; Huang W; Luo J
Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response.
Berg BB; Soares JS; Paiva IR; Rezende BM; Rachid MA; Cau SBA; Romero TRL; Pinho V; Teixeira MM; Castor MGME
J Pharmacol Exp Ther; 2021 May; 377(2):273-283. PubMed ID: 33658314
[TBL] [Abstract][Full Text] [Related]
9. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
[TBL] [Abstract][Full Text] [Related]
10. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Schmuhl E; Ramer R; Salamon A; Peters K; Hinz B
Biochem Pharmacol; 2014 Feb; 87(3):489-501. PubMed ID: 24304686
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological effects of cannabidiol by transient receptor potential channels.
Etemad L; Karimi G; Alavi MS; Roohbakhsh A
Life Sci; 2022 Jul; 300():120582. PubMed ID: 35483477
[TBL] [Abstract][Full Text] [Related]
12. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.
Mecha M; Torrao AS; Mestre L; Carrillo-Salinas FJ; Mechoulam R; Guaza C
Cell Death Dis; 2012 Jun; 3(6):e331. PubMed ID: 22739983
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
15. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Fride E; Ponde D; Breuer A; Hanus L
Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.
Lim MP; Devi LA; Rozenfeld R
Cell Death Dis; 2011 Jun; 2(6):e170. PubMed ID: 21654828
[TBL] [Abstract][Full Text] [Related]
17. Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol.
Qiao Z; Kumar A; Kumar P; Song ZH
Exp Eye Res; 2012 Jul; 100():59-64. PubMed ID: 22580290
[TBL] [Abstract][Full Text] [Related]
18. Dose-Dependent Cannabidiol-Induced Elevation of Intracellular Calcium and Apoptosis in Human Articular Chondrocytes.
Winklmayr M; Gaisberger M; Kittl M; Fuchs J; Ritter M; Jakab M
J Orthop Res; 2019 Dec; 37(12):2540-2549. PubMed ID: 31378964
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.
Sreevalsan S; Joseph S; Jutooru I; Chadalapaka G; Safe SH
Anticancer Res; 2011 Nov; 31(11):3799-807. PubMed ID: 22110202
[TBL] [Abstract][Full Text] [Related]
20. Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors.
Hanus LO; Tchilibon S; Ponde DE; Breuer A; Fride E; Mechoulam R
Org Biomol Chem; 2005 Mar; 3(6):1116-23. PubMed ID: 15750656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]